B cell targeted therapy in autoimmunity
- 31 May 2007
- journal article
- review article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 28 (2-3) , 62-68
- https://doi.org/10.1016/j.jaut.2007.02.001
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- B-Cell-Targeted Therapy for Systemic Lupus ErythematosusDrugs, 2006
- BAFF: B cell survival factor and emerging therapeutic target for autoimmune disordersEmerging Therapeutic Targets, 2003
- Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti‐CD154: A randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2002
- Immunomodulatory action of intravenous immunoglobulinImmunology, 2002
- IVIG in autoimmunity and cancer – efficacy versus safetyExpert Opinion on Drug Safety, 2002
- The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune ResponsesAnnual Review of Immunology, 2002
- Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseasesArthritis & Rheumatism, 2001
- Refractory autoimmune thrombocytopenic purpura treatment with RituximabAmerican Journal of Hematology, 2001
- New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulationAnnals of the Rheumatic Diseases, 1997
- Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.Journal of Clinical Investigation, 1994